Amyloid plaque, memory, and animal model results
Quick answer
Alzheimer's damages the memory-controlling hippocampus and language cortex, with amyloid plaque a central driver. No drug fully dissolves plaque today, but stem cells have been reported to reduce amyloid in animal models. The work EHL Bio cites gave 13 stem cell doses to Tg2576 mice and, on the Morris water maze, found cognitive and physical function improved by 23.4% with a 31.3% increase in lifespan.
The Morris water maze measures spatial memory: mice swim to find a hidden platform. Dementia-model mice keep circling without finding it, while stem cell-treated mice locate it markedly faster.
The honest limitation: mouse results do not equal human results. Alzheimer's has a long history of compounds that worked in animals and failed in human trials, so claiming stem cells treat dementia remains premature.
Better-evidenced levers for slowing cognitive decline remain blood pressure and diabetes control, regular exercise, quality sleep, treating hearing loss and staying socially engaged — alongside whatever treatment your physician advises.
If a family is considering overseas cell therapy, ask what level of human clinical data exists, whether outcomes are measured with validated cognitive scales, and what long-term follow-up is planned.
Not as standard care. Most evidence is from animal studies; patients should stay primarily under neurologist care.
The blood-brain barrier limits cell entry, which is why research increasingly focuses on secreted factors and smaller exosomes.
Earlier diagnosis helps every approach, because lost neurons cannot be recovered. Memory screening at the first signs matters most.
Major Seoul hospitals run memory clinics with amyloid PET, MRI and full neuropsychological assessment, which sharpens the treatment plan.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categoriesRelated topics: Brain & nerves